Amgen Inc (AMGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AMGN Annual Balance Sheets →
Quarterly balance sheet trends provide context on Amgen Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent13,989.00
Available-for-sale Securities, Debt Securities, Current MA13,415.00
Cash & Short-term Investments27,404.00
Accounts receivable10,227.00
Inventories6,220.00
Other current assets0.00
Total Current Assets34,961.00
Equipment/Property/Plant Net8,547.00
Goodwill net18,668.00
Intangible Assets20,487.00
Other Assets4,086.00
Total Assets95,639.00
Liabilities
Accounts Payable, Current AC2,865.00
Accrued Liabilities, Current AC17,192.00
Long-term Debt, Current Maturities LO5,445.00
Total Current Liabilities25,502.00
Long-term debt57,304.00
Other longterm debt24.00
Total Long-term Debt57,328.00
Liability for Uncertain Tax Positions, Noncurrent LI2,844.00
Deferred Income Tax Liabilities Net1,344.00
Total Liabilities83,951.00
Stockholders' Equity
Common Stock Value34,082.00
Retained Earnings / Accumulated Deficit-22,275.00
Accumulated Other Comprehensive Income-119.00
Other Equity-119.00
Common Stockholder's Equity11,688.00
Total Stockholder's Equity11,688.00
Liabilities & Stockholder's Equity95,639.00
4 historic quarters locked

Sign in to unlock the full Amgen Inc balance sheet history.

About Amgen Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000318154-26-000126

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.